4//SEC Filing
Kelly David George 4
Accession 0001209191-22-037944
CIK 0001659323other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:01 PM ET
Size
5.6 KB
Accession
0001209191-22-037944
Insider Transaction Report
Form 4
Kelly David George
Director
Transactions
- Award
Share Option (Right to Buy)
2022-06-15+647,059→ 647,059 totalExercise: $0.21Exp: 2032-06-14→ Ordinary Shares (647,059 underlying)
Footnotes (1)
- [F1]Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated 2018 Equity Incentive Plan, as amended, the shares subject to this option shall vest in full on June 15, 2023
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001624670
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:01 PM ET
- Size
- 5.6 KB